JYNT vs PATH · P/E 92, rev $30.2M vs P/E 19, rev $1.61B
The Joint Corp (JYNT) versus Uipath Inc (PATH) — a side-by-side from cached financials, not a winner call.
The Joint Corp (JYNT) is a medical care facilities company listed on US.
Uipath Inc (PATH) is a software - infrastructure company listed on US.
Latest reported JYNT revenue for 2024-09-30 was $30.2M. Net income was -$3.2M. Revenue was down 0.2% from 2024-06-30 to 2024-09-30. JYNT currently screens at market cap $117.9M and trailing P/E 91.9.
Latest reported PATH revenue for 2026-01-31 was $1.61B. Net income was $282.3M. Revenue was up 12.7% from 2025-01-31 to 2026-01-31. PATH currently screens at market cap $6.07B and trailing P/E 19.4.
JYNT currently screens at market cap $117.9M and trailing P/E 91.9. PATH currently screens at market cap $6.07B and trailing P/E 19.4.
Not investment advice. Open the JYNT and PATH stock pages for the full models.
Not investment advice.